📊 Statistics
- Analyst 1 Year Price Target:
$1.22
- Upside/Downside from Analyst Target:
21.71%
- Broker Call:
11
- Dividend Minimum 3 Year Yield:
2.31%
- EPS Growth Range (1Y):
10-25%
- Net Income Growth Range (1Y):
10-25%
- Revenue Growth Range (1Y):
0-10%
-
Upcoming Earnings Date:
2026-07-27
💰 Dividend History
Current year to date yield:
3.00%
Amount: -
Yield: -
Pay Date: 2003-06-17
Details:
10% LESS TAX
Amount: -
Yield: -
Pay Date: 2002-06-19
Details:
8% LESS TAX
📅 SGX Earnings Announcements for BSL
Raffles Medical Group Ltd (BSL)
Market: SGX |
Currency: SGD
Address: 585 North Bridge Road
Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan. The company operates through four segments: Healthcare Services, Hospital Services, Investment Holdings, and Insurance Services. Its Raffles Hospital, a tertiary care hospital that offers 24-hour acute and critical care, family medicine services, health screening, and a range of multi-disciplinary specialist clinics; appointed wards, day surgery, angiography suites, delivery suites, operating theatres, intensive care unit, and neonatal intensive care unit; and radiology, clinical laboratory, pharmacy, dietetics, rehabilitation, and traditional Chinese medicine, as well as dental services and emergency services. The company also trades in pharmaceutical and nutraceutical products, and diagnostic equipment; and provides management and consultancy services. In addition, it engages in the operation of medical clinics and other general medical services; provides specialized medical services; operation of medical laboratory and imaging center; and provision of health insurance products, as well as investment holding activities in investment properties. The company was founded in 1976 and is based in Singapore. Raffles Medical Group Ltd operates as a subsidiary of Raffles Medical Holdings Pte Ltd.
Show more
📈 Raffles Medical Group Ltd Historical Chart
🧾 Recent Financial Statement Analysis
February 23, 2026
Raffles Medical Group Ltd (2025): Full-Year Financial Analysis Raffles Medical Group Ltd released its audited financial statements for the financial year ended 31 December 2025. The report reveals continued revenue growth, profit improvement, and a robust balance sheet, positioning the…
🔎 View more in SGX corporate News 🔎 View more in SGX Financial statements
📰 Related News & Research
Showing results matched by any of: BSL, Raffles Medical Group Ltd, Raffles Medical, RFMD SP, RAFFLES MEDICAL GROUP LTD, RAFFLES MEDICAL GROUP
February 24, 2026
Broker Name: CGS International Date of Report: February 24, 2026 Excerpt from CGS International report. Report Summary Raffles Medical Group (RFMD) reported a strong 2H25 performance with PATMI up 21.7% year-on-year, driven by better operating leverage, fair value gains, and…
February 24, 2026
Broker Name: Maybank Research Pte Ltd Date of Report: February 23, 2026 Excerpt from Maybank Research Pte Ltd report. Report Summary: Raffles Medical Group reported strong 2H25 earnings, driven by hospital services growth and disciplined cost control, with a final…
February 23, 2026
Broker Name: DBS Date of Report: (Date not explicitly stated in the document. Inferred to be after FY25 results.) Excerpt from DBS report. Report Summary Raffles Medical Group reported FY25 PATMI of SGD70.6mn (+13.4% y/y) on SGD765.3mn of revenue (+1.8%…
February 23, 2026
Broker: DBS Date of Report: Inferred to be FY25 results release (exact date not specified, inferred to be recent based on "more updates to come after the briefing this morning") Excerpt from DBS report. Report Summary Raffles Medical Group reported…
February 23, 2026
Broker Name: Lim & Tan Securities Date of Report: 23 February 2026 Excerpt from Lim & Tan Securities report. Report Summary The FSSTI Index has shown an 8.0% year-to-date increase, with key indices and commodities performance summarized. OUE REIT is…
February 23, 2026
Raffles Medical Group Ltd (2025): Full-Year Financial Analysis Raffles Medical Group Ltd released its audited financial statements for the financial year ended 31 December 2025. The report reveals continued revenue growth, profit improvement, and a robust balance sheet, positioning the…
January 5, 2026
Broker Name: CGS International Date of Report: January 5, 2026 Excerpt from CGS International report. Report Summary Raffles Medical Group (RFMD) maintains a strong net cash position, enabling shareholder returns through share buybacks and potential special dividends, especially for its…
July 29, 2025
CGS International July 29, 2025 Raffles Medical Group: Incremental Growth, China Expansion, and Peer Analysis – A Deep Dive into Asia’s Healthcare Leaders Overview: Modest Growth Amid Insurance Headwinds Raffles Medical Group (RMG) continues to demonstrate steady organic growth, reporting…
June 27, 2025
Wall Street banks may be on the cusp of a massive windfall as the U.S. Federal Reserve proposes a major revision to capital rules. Analysts estimate the change could unlock as much as US$6 trillion in balance sheet capacity and…
April 26, 2025
Maybank Research Pte Ltd April 23, 2025 Raffles Medical Group: Strong Immunity – Strategic Shanghai Collaboration Drives Target Price Increase Executive Summary Raffles Medical Group (RFMD SP) has recently forged a strategic agreement with an affiliate of Shanghai Jiao Tong…
April 16, 2025
CGS International Securities Pte. Ltd. April 16, 2025 Trendspotter: Raffles Medical Group Ltd - Uptrend in an Early Stage The global market experienced significant fluctuations as President Donald Trump's evolving tariff war with major trade partners showed little signs of…
September 2, 2024
Wilmar International Ltd (WIL SP) - Benefiting from Higher Swine Prices and Stronger Currencies Recommendation: ADD Target Price: S$3.64 Stop Loss: None specified Date of Recommendation: 30th August 2024 Broker: CGS-CIMB Securities Investment Thesis: Wilmar International Ltd, a leading agribusiness…